RecruitingNCT05378139

Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization

WARD Prospective Study - Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization


Sponsor

University Hospital Bispebjerg and Frederiksberg

Enrollment

3,095 participants

Start Date

Feb 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The primary aim of this study is to test and assess the implementation and effectiveness of continuous wireless vital signs monitoring with real-time alerts on: The frequency of patients monitored with adequate data quality as adequate clinical user satisfaction in the initial versus the last part of the trial (primary outcome).


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adult participants (≥18 years)
  • Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR
  • Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia

Exclusion Criteria4

  • The participant expected not to cooperate with study procedures.
  • Allergy to plaster or silicone.
  • Having pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
  • Inability to give informed consent.

Interventions

DEVICEVital signs measurements with new app

Patients vital signs are monitored through an app for the nurses to use


Locations(1)

Rigshospitalet

Copenhagen, Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05378139


Related Trials